Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sopharma Trading ADFRA:6YH +0.74%82 PB Ratio is 0.77 as of Jul. 18, 2026, which is 82% below its 10-year median of 4.29. GuruFocus rates FRA:6YH with a GF Score™ of 82/100 and a GF Value™ of €7.38. The stock has 2 warning signs investors should review. Among 110 Medical Distribution companies, Sopharma Trading AD ranks better than 67.27% on this metric.
Sopharma Trading AD stock PB Ratio (=0.81) is close to 10-year low of 0.81.
The historical rank and industry rank for Sopharma Trading AD's PB Ratio or its related term are showing as below:
FRA:6YH'
s PB Ratio Range Over the Past 10 Years
Min: 0.8 Med: 4.29 Max: 8.88
Current: 0.81
During the past 13 years, Sopharma Trading AD's highest PB Ratio was 8.88. The lowest was 0.80. And the median was 4.29.
FRA:6YH's PB Ratio is ranked better than 67.27% of 110
companies
in the Medical Distribution industry
Industry Median: 0.995
vs FRA:6YH: 0.81
During the past 12 months, Sopharma Trading AD's average Book Value Per Share Growth Rate was 27.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 32.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 23.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sopharma Trading AD was 32.30% per year. The lowest was -1.10% per year. And the median was 3.65% per year.
Back to Basics: PB Ratio
Sopharma Trading AD (FRA:6YH) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sopharma Trading AD PB Ratio Related Terms
Sopharma Trading AD PB Ratio Historical Data
* Premium members only.
The historical data trend for Sopharma Trading AD's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sopharma Trading AD's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sopharma Trading AD (FRA:6YH) has a PB Ratio of 0.77 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sopharma Trading AD and its competitors. This is 82% below median its historical median of 4.29. Over the past decade, Sopharma Trading AD's PB Ratio has ranged from 0.80 to 8.88. According to the industry distribution chart, Sopharma Trading AD ranks #36 out of 110 companies in the Medical Distribution industry, placing it in the top 32.7%.
Is Sopharma Trading AD's PB Ratio too high?
Sopharma Trading AD's current PB Ratio of 0.77 is 82% below median its 10-year median of 4.29. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 8.88. The Medical Distribution industry median PB Ratio is 1.00. Sopharma Trading AD's value of 0.77 is 22.6% below this industry median. Based on the distribution chart, Sopharma Trading AD ranks #36 out of 110 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sopharma Trading AD has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma Trading AD ranks #36 out of 110 companies for PB Ratio. This puts Sopharma Trading AD in the upper half of its industry. The industry median PB Ratio is 1.00. Sopharma Trading AD's value of 0.77 is 22.6% below this benchmark. Historically, Sopharma Trading AD's own PB Ratio has ranged from 0.80 to 8.88 over the past decade. While the company's 10-year median is 4.29 vs. the industry median of 1.00, Sopharma Trading AD has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma Trading AD's current PB Ratio of 0.77 is 22.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sopharma Trading AD and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Trading AD's current PB Ratio is 0.77, which is 82% below median its own 10-year median of 4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Sopharma Trading AD (FRA:6YH) has a current PB Ratio of 0.77. The stock's GF Value™ is €7.38, compared to a current price of €2.74 — trading 62.9% below its estimated fair value. The current PB Ratio is 0.77, which is 82% below median its 10-year median of 4.29 and 22.6% below the Medical Distribution industry median of 1.00. Sopharma Trading AD's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sopharma Trading AD (FRA:6YH), the current PB Ratio is 0.77 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Trading AD (FRA:6YH) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued.
The current stock price of €2.74 is trading 62.9% below its estimated GF Value™ of €7.38.
Key valuation signals for FRA:6YH:
PB Ratio: 0.77 (82% below median its 10-year median of 4.29)
GF Value™: €7.38 vs. price of €2.74 (62.9% below fair value)
Industry Position: 22.6% below the Medical Distribution median (#36 of 110)
No single metric tells the full story. See the FRA:6YH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
82GF Score
Get the complete analysis for FRA:6YH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6YH has been successfully added to your 
